Bio
Dr. Heather Wakelee specializes in the treatment of lung cancer, thymoma and mesothelioma. She completed all post-graduate training at Stanford University and joined the faculty in 2003. For many years she was the physician lead for the thoracic malignancies clinical research group and has developed research programs related to lung cancer and thymoma across multiple areas including clinical trials, translation work and population sciences. She is the Principal Investigator on numerous clinical trials. In 2021 Dr. Wakelee took on the role of Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology. She is also active in many national and international organizations related to lung cancer and thymoma including leadership roles in the International Association for the Study of Lung Cancer (IASLC).
Clinical Focus
- Cancer > Thoracic Oncology
- Lung Cancer - Medical Oncology
- Investigational Therapeutics
- Medical Oncology
- thymoma
- Mesothelioma
- thymic carcinoma
- Thoracic Cancers - Medical Oncology
- Mesothelioma - Medical Oncology
- Oncology (Cancer)
- Thoracic Cancers
Academic Appointments
-
Professor - Med Center Line, Medicine - Oncology
-
Member, Stanford Cancer Institute
Honors & Awards
-
Merit Award, American Society of Clinical Oncology (05/2003)
-
Alpha Omega Alpha, Johns Hopkins University (06/1996)
-
Teaching Award, Stanford University Division of Oncology (2007, 2008, 2009, 2011)
-
Young Investigator Award, ECOG-ACRIN (2015)
Professional Education
-
Fellowship: Stanford University Division of Oncology (2003) CA
-
Residency: Stanford University Internal Medicine Residency (1999) CA
-
Board Certification: American Board of Internal Medicine, Medical Oncology (2003)
-
Medical Education: Johns Hopkins University School of Medicine (1996) MD
-
M. D., Johns Hopkins University, Medicine (1996)
-
A.B., Princeton University, Molecular Biology (1992)